Quantcast
Channel: Endpoints News
Viewing all articles
Browse latest Browse all 3533

FDA clears in vivo blood stem cell editing trial; Abeona's $155M PRV sale

$
0
0
Plus, news about CytomX, Valneva, Lenz and Lotus Pharmaceutical: 🧪 After China, US greenlights first trial of in vivo blood stem cell editing: Ensoma

Viewing all articles
Browse latest Browse all 3533

Trending Articles